|
ITSN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.707980E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.801800E-01 |
| Normal-vs-Stage2 |
8.551200E-01 |
| Normal-vs-Stage3 |
1.455750E-02 |
| Normal-vs-Stage4 |
1.664890E-03 |
| Stage1-vs-Stage2 |
8.393200E-01 |
| Stage1-vs-Stage3 |
5.363500E-03 |
| Stage1-vs-Stage4 |
8.596300E-04 |
| Stage2-vs-Stage3 |
1.117160E-01 |
| Stage2-vs-Stage4 |
4.222000E-02 |
| Stage3-vs-Stage4 |
4.593200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.134200E-01 |
| Normal-vs-AfricanAmerican |
4.374400E-02 |
| Normal-vs-Asian |
2.007600E-01 |
| Caucasian-vs-AfricanAmerican |
2.548800E-01 |
| Caucasian-vs-Asian |
2.104200E-01 |
| AfricanAmerican-vs-Asian |
6.256200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.095600E-02 |
| Normal-vs-Female |
8.395200E-01 |
| Male-vs-Female |
7.400300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.158230E-02 |
| Normal-vs-Age(41-60Yrs) |
6.545200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.148790E-01 |
| Normal-vs-Age(81-100Yrs) |
2.238400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.588200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.978990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.549200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.236600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.499000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.093800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.897500E-02 |
| Normal-vs-Grade 2 |
6.501400E-01 |
| Normal-vs-Grade 3 |
5.594000E-02 |
| Normal-vs-Grade 4 |
2.24549999999768E-05 |
| Grade 1-vs-Grade 2 |
1.850820E-01 |
| Grade 1-vs-Grade 3 |
3.200100E-03 |
| Grade 1-vs-Grade 4 |
5.77389999999456E-05 |
| Grade 2-vs-Grade 3 |
6.858500E-03 |
| Grade 2-vs-Grade 4 |
9.14669999962925E-07 |
| Grade 3-vs-Grade 4 |
2.478000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.305600E-02 |
| Normal-vs-ccB subtype |
3.804100E-03 |
| ccA subtype-vs-ccB subtype |
1.2025999995835E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.340600E-01 |
| Normal-vs-N1 |
2.262200E-01 |
| N0-vs-N1 |
3.758000E-01 |
|
|
